Literature DB >> 8100987

N-acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia.

M Cassidy1, J H Neale.   

Abstract

N-Acetylaspartylglutamate (NAAG) is a nervous system-specific, acidic dipeptide which is released from neurons in a manner consistent with a function in synaptic neurotransmission. The hydrolysis of NAAG to produce glutamate and N-acetylaspartate was analyzed in cell cultures prepared from murine brain cells. Peptidase activity against NAAG was found in cultures which contained both neurons and glia, as well as in cultures of glia alone. Several lines of evidence were obtained in support of the hypothesis that this peptidase activity is predominantly bound to the extracellular face of the plasma membranes of these cells. Glutamate released from NAAG accumulated in the extracellular medium. Extracellular application of peptidase inhibitors effectively reduced NAAG hydrolysis. Peptidase activity was not secreted into the cell culture medium by intact cells, and lysed cells did not release detectable peptidase activity beyond that obtained with intact cells. Replacement of extracellular sodium with choline inhibited peptide uptake while stimulating apparent extracellular NAAG hydrolysis by intact cells in culture. Finally, the steady rise in extracellular glutamate as a consequence of NAAG hydrolysis by these brain cells, including glia, supports the conclusion that glutamate uptake is not tightly coupled to peptidase activity and thus that NAAG serves as a significant source of glutamate in the synaptic space following depolarization-induced peptide release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100987     DOI: 10.1016/0143-4179(93)90015-3

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  11 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

2.  GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.

Authors:  Ajit G Thomas; Amos Bodner; Ghanashyam Ghadge; Raymond P Roos; Barbara S Slusher
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

3.  Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.

Authors:  Joseph O'Neill; Eda Gorbis; Jamie D Feusner; Jenny C Yip; Susanna Chang; Karron M Maidment; Jennifer G Levitt; Noriko Salamon; John M Ringman; Sanjaya Saxena
Journal:  J Psychiatr Res       Date:  2013-01-04       Impact factor: 4.791

4.  Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II.

Authors:  R Luthi-Carter; U V Berger; A K Barczak; M Enna; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Changes in metabolites in the brain of patients with fibromyalgia after treatment with an NMDA receptor antagonist.

Authors:  Nicolas Fayed; Barbara Oliván; Yolanda Lopez Del Hoyo; Eva Andrés; Mari Cruz Perez-Yus; Alicia Fayed; Luisa F Angel; Antoni Serrano-Blanco; Miquel Roca; Javier Garcia Campayo
Journal:  Neuroradiol J       Date:  2019-06-19

6.  GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Authors:  Emilio R Garrido Sanabria; Krystyna M Wozniak; Barbara S Slusher; Asaf Keller
Journal:  J Neurophysiol       Date:  2003-08-13       Impact factor: 2.714

7.  Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models.

Authors:  Ghanashyam D Ghadge; Barbara S Slusher; Amos Bodner; Mauro Dal Canto; Krystyna Wozniak; Ajit G Thomas; Camilo Rojas; Takashi Tsukamoto; Pavel Majer; Richard J Miller; Anna Liza Monti; Raymond P Roos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

8.  Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.

Authors:  Daiying Zuo; Tomasz Bzdega; Rafal T Olszewski; John R Moffett; Joseph H Neale
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

9.  Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies.

Authors:  Camilo Rojas; Marigo Stathis; Michael Polydefkis; Michelle A Rudek; Ming Zhao; Gigi J Ebenezer; Barbara S Slusher
Journal:  J Transl Med       Date:  2011-03-09       Impact factor: 5.531

10.  Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.

Authors:  Anthony Bejjani; Joseph O'Neill; John A Kim; Andrew J Frew; Victor W Yee; Ronald Ly; Christina Kitchen; Noriko Salamon; James T McCracken; Arthur W Toga; Jeffry R Alger; Jennifer G Levitt
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.